Welcome to visit Zhongnan Medical Journal Press Series journal website!
Zhongnan Medical Journal Press
Series of Journals
Center for Evidence-Based and Translational Medicine of Wuhan University
The title
The title
The keywords
The author
Submit
Home
About us
Journal Introduction
Chief Editor
Editorial Committee
Author Center
Submission Guide
Assignment Agreement
ConflictofInterest
Articles
Subscribe
Copyright
Contact us
Draft submission system
Author login
Author register
Reviewer login
Editor login
Home
Articles
Vol 34,2025 No.9
The title
The title
The keywords
The author
New Online
Vol 34,2025
Vol 33,2024
Vol 32,2023
No.9
No.8
No.7
No.6
No.5
No.4
No.3
No.2
No.1
Contents
Vol 34,2025 No.9
Date of publication: September 15, 2025
Get cover
Get contents
Prev
Vol 34,2025 No.8
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (8): development of statistical analysis strategies and key considerations
WANG Qing
FENG Xinyan
WANG Dandan
Gu Zenan
MAO Guangyun
WANG Yi
2025,34(9):993-1003
Pharmacoepidemiology
Methodology
Guildelines
Statistical analysis strategies
Bias control
Details
Download
Mobile
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (9): research report standards and results visualization
CHENG Jingru
CHEN Ruina
LI Jiarui
TANG Shaowen
SUN Feng
ZHAN Siyan
2025,34(9):1004-1016
Pharmacoepidemiology
Methodology
Guildelines
Research report
Visualization
Details
Download
Mobile
Association of ondansetron use with short- and long-term prognosis in patients with severe cerebrovascular disease: a retrospective cohort study based on the MIMIC-Ⅳ database
QIN Sisi
ZHOU Yuping
XIAO Jijie
2025,34(9):1017-1024
Ondansetron
Severe cerebrovascular disease
Prognosis
MIMIC-Ⅳ database
Details
Download
Mobile
Observation on the efficacy of Huoluo Xiaotong capsules in treating cervical spondylosis radiculopathy: a real-world study
LAN Xiangzhou
ZENG Weike
ZHOU Shasha
KUANG Gaoyan
GUO Cheng
CHEN Qing
2025,34(9):1025-1031
Cervical spondylosis radiculopathy
Huoluo Xiaotong capsules
Real-world study
Efficacy evaluation
Details
Download
Mobile
Risk factors of vancomycin-related acute kidney injury in elderly patients based on machine learning
GUO Xinyu
DAI Libo
YANG Hongxin
2025,34(9):1032-1041
Vancomycin
Acute kidney injury
Elderly patients
Risk factor
Machine learning
Details
Download
Mobile
Study on the effects of sitagliptin and metformin combined with zoledronic acid on glycolipid metabolism and bone metabolism levels in patients with diabetes mellitus complicated with osteoporosis
CHEN Lu
HUANG Ye
GAO Peilin
HUANG Lingli
DING Rong
2025,34(9):1042-1048
Type 2 diabetes mellitus
Osteoporosis
Sitagliptin and metformin
Zoledronic acid
Glucose and lipid metabolism
Bone metabolism
Details
Download
Mobile
KAP investigation and influential factor analysis on the risk of medication safety behavior among cancer patients in western Yunnan
QUE Suyun
MA Qiaoling
ZHOU Xia
CUN Yufang
LI Bin
XU Shidong
MA Xi'na
2025,34(9):1049-1056
Medication safety
Behavioral risk
Knowledge-attitude-behavior
Oncology patients
Factors affecting
Details
Download
Mobile
Tirzepatide in the treatment of type 2 diabetes mellitus: a rapid health technology assessment
ZHANG Yunxuan
ZHOU Haifeng
GAO Ningzhou
WU Jianbo
QIAN Cheng
ZHANG Min
GUO Han
SONG Zhongjuan
LIU Xiaoyan
2025,34(9):1057-1065
Tirzepatide
Type 2 diabetes mellitus
Rapid health technology assessment
Efficacy
Safety
Cost-effectiveness
Details
Download
Mobile
Expert consensus for off-label drug use of rare disease: a protocol
CHEN Chaoyang
DUAN Yuehan
ZHUO Lin
HE Guohua
ZHANG Yanqin
ZHOU Ying
WANG Shengfeng
CUI Yimin
DING Jie
2025,34(9):1066-1073
Rare disease
Off-label use
Expert consensus
Study protocol
Details
Download
Mobile
Large language models empowering pharmacoepidemiology research
SI Shucheng
WU Liuliu
WANG Conghui
YANG Ziming
DU Jian
WANG Shengfeng
ZHAN Siyan
2025,34(9):1074-1083
Artificial intelligence
Large language models
Pharmacoepidemiology
Drug discovery
Drug repurposing
Pharmacovigilance
Details
Download
Mobile
Research progress on the mechanism of regulating bilirubin metabolism by traditional Chinese medicines attributed to the liver meridian
JIANG Mengting
XIAN Zicheng
ZHOU Yinmin
CHEN Chao
LI Xue
YANG Ming
2025,34(9):1084-1093
Bilirubin
UGT1A1 enzyme
Drug transporters
Traditional Chinese medicine
Meridian tropism of liver
Details
Download
Mobile
Clinical pharmacist participated in the drug treatment practice of a patient with ulcerative colitis accompanied by facial aseptic abscesses
WU Liping
ZHANG Peipei
HU Naizhong
WANG Yanyan
2025,34(9):1094-1098
Ulcerative colitis
Aseptic abscess
Parenteral manifestation
Infliximab
Pharmaceutical care
Details
Download
Mobile
A case of tumor hyperprogression caused by treatment of lung squamous cancer with serplulimab
YING Yuanyuan
MOU Yongxiao
ZHU Qiuna
ZHENG Song
LOU Songgao
LOU Jiang
2025,34(9):1099-1103
Serplulimab
Hyperprogression
Immune checkpoint inhibitors
Adverse drug reaction
Details
Download
Mobile
A case report of acute kidney injury associated with pegylated recombinant human granulocyte colony-stimulating factor injection
ZHONG Hong
QIU Hongbo
ZHANG Xuanyi
KONG Wenqiang
2025,34(9):1104-1107
Pegylated recombinant human granulocyte colony-stimulating factor
Acute kidney injury
Adverse drug reaction
Details
Download
Mobile
Ertugliflozin-induced euglycemic diabetic ketoacidosis: a case report
PAN Xuefen
DAI Li
SHAO Lingxia
AI Jianguo
2025,34(9):1108-1112
Ertugliflozin
Euglycemic diabetic ketoacidosis
Adverse drug reaction
Details
Download
Mobile